Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma

Phase 2ART27.13Positive

AI Analysis

Summary

Artelo announced the enrollment of the first patient in a Phase 2 clinical trial evaluating ART27.13 for glaucoma treatment, an investigator-led study funded by Glaucoma UK and the HSC R&D Division.

Clinical Trial Data

Phase

Phase 2

Patients

Outcome Details

First patient enrolled in Phase 2 clinical trial

Importance:5/10

Sentiment:

0.60

clinical trialPhase 2ophthalmologyglaucomapatient enrollment

Related Companies

$ARTL

Read the original article

Published by GlobeNewswire Clinical Studies on August 10, 2026 12:47 PM

Read Original